chr7-51027891-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015198.5(COBL):āc.3205A>Gā(p.Lys1069Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015198.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COBL | NM_015198.5 | c.3205A>G | p.Lys1069Glu | missense_variant | 10/13 | ENST00000265136.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COBL | ENST00000265136.12 | c.3205A>G | p.Lys1069Glu | missense_variant | 10/13 | 1 | NM_015198.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251378Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135850
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 727226
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2023 | The c.3205A>G (p.K1069E) alteration is located in exon 10 (coding exon 10) of the COBL gene. This alteration results from a A to G substitution at nucleotide position 3205, causing the lysine (K) at amino acid position 1069 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at